Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dzikova

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Transplantation Proceedings|October 24, 2007
Do we have to treat subclinical rejections in early protocol renal allograft biopsies?J Masin-Spasovska, G Spasovski, S Dzikova, et al.
Artificial Organs|August 1, 1995
Hantaan virus infection with acute renal failureM Polenaković, L Grcevska, V Gerasimovska-Tanevska, et al.
Transplantation Proceedings|April 26, 2005
Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcomeJ Masin-Spasovska, G Spasovski, S Dzikova, et al.
Prilozi|January 10, 2006
Recurrent glomerulonephritis in living kidney transplantationG Spasovski, N Ivanovski, J Masin-Spasovska, et al.
Prilozi|July 25, 2006
ANCA-GBM dot-blot test in diagnosis of patients with glomerulonephritisM Milovanceva-Popovska, L Grcevska, S Dzikova, et al.
Prilozi|January 10, 2006
Chronic allograft nephropathy (CAN) in early renal protocol biopsies: does treatment of borderline and subclinical acute rejections prevent development and progression of CAN?J Masin-Spasovska, G Spasovski, M Polenaković, et al.
Prilozi|August 25, 2005
The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsiesJ Masin-Spasovska, G Spasovski, S Dzikova, et al.
Bratislavske Lekarske Listy|September 30, 2011
Aminotransferase activity as a poor predictor of liver disease progression in dialysis patients with chronic hepatitis CP Dzekova-Vidimliski, G Severova-Andreevska, L Trajceska, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Transplantation Proceedings|October 24, 2007
Do we have to treat subclinical rejections in early protocol renal allograft biopsies?J Masin-Spasovska, G Spasovski, S Dzikova, et al.
Artificial Organs|August 1, 1995
Hantaan virus infection with acute renal failureM Polenaković, L Grcevska, V Gerasimovska-Tanevska, et al.
Transplantation Proceedings|April 26, 2005
Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcomeJ Masin-Spasovska, G Spasovski, S Dzikova, et al.
Prilozi|January 10, 2006
Recurrent glomerulonephritis in living kidney transplantationG Spasovski, N Ivanovski, J Masin-Spasovska, et al.
Prilozi|July 25, 2006
ANCA-GBM dot-blot test in diagnosis of patients with glomerulonephritisM Milovanceva-Popovska, L Grcevska, S Dzikova, et al.
Prilozi|January 10, 2006
Chronic allograft nephropathy (CAN) in early renal protocol biopsies: does treatment of borderline and subclinical acute rejections prevent development and progression of CAN?J Masin-Spasovska, G Spasovski, M Polenaković, et al.
Prilozi|August 25, 2005
The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsiesJ Masin-Spasovska, G Spasovski, S Dzikova, et al.
Bratislavske Lekarske Listy|September 30, 2011
Aminotransferase activity as a poor predictor of liver disease progression in dialysis patients with chronic hepatitis CP Dzekova-Vidimliski, G Severova-Andreevska, L Trajceska, et al.
Pageof 2